Recent Quarter Total Invested
$2.02 M
Recent Quarter Institutional Ownership Percentage
11.99%
Total Invested of Last Quarter
$2.32 M
Ownership Percentage of Last Quarter
11.36%
PharmaCyte Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 08/14/2024 | 327,503 | $641,906 | 0.00% | 3.81% |
| VANGUARD GROUP INC | 08/13/2024 | 192,387 | $377,079 | 10.19% | 2.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 176,605 | $346,171 | -11.82% | 2.05% |
| EQUITEC PROPRIETARY MARKETS, LLC | 07/12/2024 | 82,727 | $162,145 | 0.00% | 0.96% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 54,834 | $107,474 | 33.13% | 0.64% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 48,500 | $95,060 | 10.73% | 0.56% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 27,750 | $54,390 | 100.00% | 0.32% |
| UBS GROUP AG | 08/14/2024 | 27,575 | $54,047 | 306,288.89% | 0.32% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 25,596 | $50,168 | 4.21% | 0.30% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 23,700 | $46,452 | 0.85% | 0.28% |
| NORTHERN TRUST CORP | 08/14/2024 | 19,208 | $37,648 | -0.11% | 0.22% |
| BLACKROCK INC. | 08/13/2024 | 13,346 | $26,158 | -36.76% | 0.16% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 7,384 | $14,473 | 128.68% | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 2,851 | $5,000 | -20.56% | 0.03% |
| ASPIRE PRIVATE CAPITAL, LLC | 07/15/2024 | 800 | $1,568 | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 513 | $1,004 | -70.97% | 0.01% |
| KELLY FINANCIAL SERVICES LLC | 08/12/2024 | 234 | $459 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 152 | $298 | 181.48% | 0.00% |
| PLANNING CAPITAL MANAGEMENT CORP | 08/12/2024 | 100 | $196 | 100.00% | 0.00% |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 08/09/2024 | 69 | $135 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 19 | $37 | 5.56% | 0.00% |
| SACHETTA, LLC | 08/07/2024 | 14 | $28 | 0.00% | 0.00% |
| BFSG, LLC | 07/29/2024 | 5 | $10 | -28.57% | 0.00% |
| MORGAN STANLEY | 10/17/2024 | 3 | $7 | 0.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 08/16/2024 | 2 | $4 | -33.33% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CWM, LLC | 07/10/2024 | 0 | $0 | -100.00% | 0.00% |
| COVESTOR LTD | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
PharmaCyte Biotech, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of PMCB shares?
During the previous two years, 16 institutional investors and hedge funds held shares of PharmaCyte Biotech, Inc.. The most heavily invested institutionals were:
TWO SIGMA SECURITIES, LLC: 0
Redwood Wealth Management Group, LLC: 0
Kelly Financial Services LLC: 0
K2 PRINCIPAL FUND, L.P.: 327,503
GEODE CAPITAL MANAGEMENT, LLC: 176,605
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 54,834
-
What percentage of PharmaCyte Biotech, Inc. stock is owned by institutional investors?
11.99% of PharmaCyte Biotech, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at PMCB ?
Institutional investors have bought a total of 717,734 shares in the last 24 months. This purchase volume represents approximately $1.15 M in transactions.